A Pilot Study of Oxaloacetate in Subjects With Treated PD

Summary

The purpose of this study is to determine if Oxaloacetate (OAA) is a safe and effective treatment for Parkinson's disease. Each subject will be asked to make 3 study visits and complete two safety follow-up phone calls over a 4 month period.

Timeline

Start

2012-12

Primary completion

2014-10

Completion

2014-10

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Oxaloacetate (OAA) vs Placebo; p = 0.50; t-test, 2 sided NCT01741701 ↗

Drugs

Indications